V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
A
ANIPAI Stock Diagnostic Report

ANI Pharma reports positive phase 4 data for Iluvien in non-infectious uveitis

ANI Pharma's announcement of positive Phase 4 data for Iluvien, a non-infectious uveitis treatment, is expected to act as a positive catalyst for the stock price.

View Source Article ↗
AI CATALYST SCORE65 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

ANIP Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-10-12 15:42:29ANIP65MidView Report →
2026-08-07 18:51:47ANIP85MidView Report →
2026-08-07 10:59:12ANIP85MidView Report →
View Full History for ANIP (Blueprint) →